XML 131 R105.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Financial Instruments were Denominated in U S Dollars (Detail) - CAD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Disclosure of detailed information about financial instruments [Line Items]    
Cash $ 21,587 $ 40,588
Accounts receivable 413,925 255,740
Accounts payable and accrued liabilities (392,053) (224,123)
Canadian Operations [Member] | Currency Risk [Member]    
Disclosure of detailed information about financial instruments [Line Items]    
Cash 264 2,398
Accounts receivable 215 14
Accounts payable and accrued liabilities (28,041) (29,427)
Long-term liabilities, excluding long-term incentive plans 0 0
Net foreign currency exposure (27,562) (27,015)
Impact of $0.01 change in the U.S. dollar to Canadian dollar exchange rate on net earnings (loss) (276) (270)
Impact of $0.01 change in the U.S. dollar to Canadian dollar exchange rate on comprehensive loss 0 0
Foreign Operations [Member] | Currency Risk [Member]    
Disclosure of detailed information about financial instruments [Line Items]    
Cash 13,421 17,382
Accounts receivable 175,543 115,614
Accounts payable and accrued liabilities (101,531) (81,971)
Long-term liabilities, excluding long-term incentive plans [1] (14,542) (14,781)
Net foreign currency exposure 72,891 36,244
Impact of $0.01 change in the U.S. dollar to Canadian dollar exchange rate on net earnings (loss) 0 0
Impact of $0.01 change in the U.S. dollar to Canadian dollar exchange rate on comprehensive loss $ 729 $ 362
[1] Excludes U.S. dollar long-term debt that has been designated as a hedge of the Corporation’s net investment in certain self-sustaining foreign operations.